Investor · St. Louis, MO

Chris C. Wilkins

Open Chris in the network graph →

Filings

8

SEC Form D

Connections

75

co-filers

Capital

$309.1M

across filings

Active

Dec 2019

to Jul 2023

Most-connected co-filers (75)

Natalie B. Dinicola · St. Louis, MO8 shared Michael B. Wainscott · St. Louis, MO8 shared Andy M. Wheeler · St. Louis, MO5 shared Matthew B. Crisp · Durham, NC5 shared Nilesh C. Kumar · Watertown, MA3 shared David Kabakoff · San Diego, CA3 shared Sharon Love · NEW YORK, NY3 shared Richard J. O'Toole · New York, NY3 shared L. A. Hodges · Fort Worth, TX3 shared Aymeric S. Sallin · Watertown, MA3 shared Andrew Newcomb · Philadelphia, PA3 shared Peter E. Wirth · Cambridge, MA3 shared Ronald J. Seubert · Seattle, WA3 shared William B. Janes · Chicago, IL3 shared Kenneth Wong · New York, NY3 shared Peter Feret · NEW YORK, NY3 shared Andrew J. Schwab · Seattle, WA3 shared Joseph J. Victor Jr · Seattle, WA3 shared Michael J. Metzger · Watertown, MA3 shared Guido J. Magni · Watertown, MA3 shared Dennis J. Ausiello · Watertown, MA3 shared Justin G. Lioi · New York, NY3 shared Stephan S. Dolezalek · Boulder, CO2 shared Dan B. Jacobi · Durham, NC2 shared

Recent filings (8)

RareCyte, Inc.Jul 2023 · 22 co-filers$35.7M Tarveda Therapeutics, Inc.Sep 2021 · 17 co-filers$6.0M RareCyte, Inc.Sep 2021 · 20 co-filers$24.0M Tarveda Therapeutics, Inc.Dec 2020 · 17 co-filers$15.4M Benson Hill, Inc.Dec 2020 · 37 co-filers$159.1M Benson Hill, Inc.Nov 2020 · 37 co-filers$150.0M RareCyte, Inc.Dec 2019 · 16 co-filers$22.2M Tarveda Therapeutics, Inc.Dec 2019 · 20 co-filers$13.6M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Chris in the interactive graph →